News release: Renishaw’s integrated neurosurgery solution cleared for sale in USA (docx)
The Food and Drug Administration (FDA) has recently cleared the use of Renishaw’s neuromate® Gen III surgical robot with the neuroinspire™ surgical planning software in the USA. Both were previously cleared for use separately, but not in combination ─ This latest clearance means that neurosurgeons across America will now be able to deliver surgical plans created using neuroinspire software directly using the neuromate surgical robot, helping to improve patient outcomes.
This type of file requires a viewer, freely available from Microsoft
Didn't find what you were looking for?
Tell us what you couldn’t find and we will do our best to help.